Roche Diabetes Care launches a new system that facilitates personalized treatment to people with insulin -dependent diabetes
Published studies (1) show that between 43% and 64% of people with type 1 diabetes, they poorly calculate the daily doses of rapid insulin that are administered to cover their daily intakes, which means that halfProper control of your illness, with negative consequences in the short and long term for your health.
• People in intensive insulin therapy will already have a safe decision-making device, ACCU-Chek Aviva Expert, which will allow them to perform precise calculations on the different bowling or doses that must be administered throughout the day.
• Prior to its official presentation in May, Roche Diabetes Care, has just finished an important campaign during the months of March and April, to inform and train endocrine and educators throughout the country, in the management of the new customization device of theinsulin therapy, which will radically change the treatment approach.
One hundred professionals among endocrine and educators attended the first of the campaign days, which started in Madrid on March 8, and that have been carried out until ending April, in the most important cities of the Spanish geography.
The structured days in practical workshops have allowed specialists to know the numerous possibilities, and become familiar with the ACCU-Chek Aviva Expert device.In them, the needs raised by the specialists have been collected, to carry out an adequate control of the people in intensive therapy, taking into account the worrying figures that the studies show, since between 43% and 64% (1) they performThe calculations of insulin bowling, which must be administered daily.In this sense ACCU-Chek Aviva Expert, provides solutions to achieve the control and optimization objectives of therapy.
Until now, calculating the dose of insulin overview was not easy for diabetic people.In the words of Dr. Juan Ramón Calle, of the Endocrinology Service of the San Carlos Clinical Hospital of Madrid, (which intervened on the first training day in Madrid) “Power finally have the first bolus calculator for the people who need dailyIntensive insulin therapy was very anticipated. ”
A personalized therapy, which in three simple steps will allow optimal glycemia control, reducing the usual problems in intensive insulin treatment, such as hypoglycemia episodes, which so negatively affect short and long term health.
ACCU-Chek Aviva Expert, previously adjusted by the endocrine with the parameters of each person (blocks of time according to intake schedules, insulin ratio-carbon hydroly, sensitivity factor, physical exercise, etc.) optimizes the therapy, and providesnumerous benefits to those people committed to achieving good control of their diabetes, and a substantial improvement of their quality of life.
Health education is a subject of special importance to ensure a better quality of life and in this sense, Roche Diabetes Care, in addition to the realization of these days throughout Spain, has developed support materials, which will be available both for bothSpecialists, educators and people with diabetes, together with the informative website, and a permanent service of 24 hours, seven days a week.
